Skip to content

Drug interactions

Dacomitinib + Nebivolol

Severity: Moderate

Dacomitinib and Nebivolol: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Dacomitinib is a strong CYP2D6 inhibitor and can substantially raise exposure to nebivolol, which depends on CYP2D6 for clearance. This may cause excessive bradycardia and hypotension.

What this interaction means in plain words

Dacomitinib and Nebivolol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Dacomitinib belongs to Oncology; Nebivolol belongs to Cardiovascular.

Evidence level: Moderate

Why it happens

Inhibition of CYP2D6-mediated nebivolol metabolism by dacomitinib.

What to do

Monitor heart rate and blood pressure and lower the nebivolol dose if bradycardia or hypotension develops. Consider an alternative beta-blocker not cleared by CYP2D6 if needed.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Dacomitinib and Nebivolol, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Dacomitinib with Nebivolol?

MediHelp rates the interaction as moderate. Dacomitinib and Nebivolol can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Dacomitinib is a strong CYP2D6 inhibitor and can substantially raise exposure to nebivolol, which depends on CYP2D6 for clearance. This may cause excessive bradycardia and hypotension.

How serious is the interaction between Dacomitinib and Nebivolol?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor heart rate and blood pressure and lower the nebivolol dose if bradycardia or hypotension develops. Consider an alternative beta-blocker not cleared by CYP2D6 if needed.

What other medicines interact with Nebivolol?

MediHelp also lists interactions of Nebivolol with, for example, Acebutolol, Aldesleukin, Amiodarone. The full list is on the Nebivolol page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in